Loading...
Loading...
Among the 7 tracked institutional investors we monitor, AUPH (AURINIA PHARMACEUTICALS INC) is held with a combined value of $213.99M across 14,328,960 shares. The largest holder is BlackRock, Inc. with a position worth $116.27M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$213.99M
Total Shares Held
14,328,960
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $116.27M | 0.00% | -1.0% |
| 2 | STATE STREET CORP | $37.45M | 0.00% | +1.0% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $24.66M | 0.04% | +4.6% |
| 4 | VANGUARD GROUP INC | $23.13M | 0.00% | New |
| 5 | CITADEL ADVISORS LLC | $6.03M | 0.00% | -58.3% |
| 6 | FMR LLC | $4.72M | 0.00% | +18.8% |
| 7 | MILLENNIUM MANAGEMENT LLC | $1.74M | 0.00% | -84.1% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of AUPH with a position worth $116.27M, representing 0.00% of their portfolio. In total, 7 institutional investors hold AUPH with a combined value of $213.99M.
In the most recent quarter, 1 fund opened a new position in AUPH. Additionally, 3 increased their holdings and 3 reduced their positions.
Institutional investors hold $213.99M worth of AUPH stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $116.27M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For AUPH, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their AUPH positions.